date,title,source
Oct-24-18,Catalyst Biosciences Receives A Notice of Allowance from The Japan Patent Office Covering Modified Factor X Polypeptides,GlobeNewswire
Oct-25-18,"Factors of Influence in 2018, Key Indicators and Opportunity within StoneMor Partners, Catalyst Biosciences, Kennametal, Emergent Biosolutions, Kimball International, and Tailored Brands  New Research Emphasizes Economic Growth",GlobeNewswire
Nov-01-18,Catalyst Biosciences Reports Third Quarter Operating & Financial Results and Provides a Corporate Update,GlobeNewswire
Nov-21-18,What Did Catalyst Biosciences Incs (NASDAQ:CBIO) CEO Take Home Last Year?,Simply Wall St.
Dec-10-18,Catalyst Biosciences to Host a Research & Development Day Focused on Factor VIIa and Factor IX Hemophilia Programs,GlobeNewswire
Dec-18-18,Catalyst Biosciences Hosts Research & Development Day Focused on Factor VIIa and Factor IX Hemophilia Programs,GlobeNewswire
Jan-08-19,These 5 Stocks Make Great Buys on New Analyst Coverage,Zacks
Jan-09-19,"Zacks.com featured expert Kevin Matras highlights: Net Lease, K12, Brookline Bancorp, Catalyst Biosciences and Knoll",Zacks
Jan-22-19,"Is Catalyst Biosciences, Inc.s (NASDAQ:CBIO) Balance Sheet A Threat To Its Future?",Simply Wall St.
Jan-31-19,Catalyst Biosciences Announces Oral and Poster Presentations at the 12th Annual Congress of the European Association for Haemophilia and Allied Disorders,GlobeNewswire
Feb-05-19,Catalyst Biosciences to Present at the Annual BIO CEO & Investor Conference,GlobeNewswire
Feb-06-19,Catalyst Biosciences Announces Preclinical Proof-of-Concept Data of Gene Therapy Candidate CB 2679d-GT for the Treatment of Hemophilia B,GlobeNewswire
Feb-08-19,Catalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors at the 12th Annual EAHAD Congress,GlobeNewswire
Feb-19-19,"New Research: Key Drivers of Growth for Omega Healthcare Investors, Cinedigm, Cardiovascular, Allegiant Travel, Catalyst Biosciences, and ESCO Technologies  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Mar-06-19,Catalyst Biosciences Announces Poster Presentation at the Association for Research in Vision and Ophthalmology Annual Meeting,GlobeNewswire
Mar-07-19,Catalyst Biosciences Reports Fourth Quarter and Full-Year 2018 Operating & Financial Results and Provides a Corporate Update,GlobeNewswire
Apr-01-19,"Could The Catalyst Biosciences, Inc. (NASDAQ:CBIO) Ownership Structure Tell Us Something Useful?",Simply Wall St.
Apr-01-19,Catalyst Biosciences Receives Orphan Designation from the European Commission for Marzeptacog Alfa (Activated),GlobeNewswire
Apr-02-19,Catalyst Biosciences Initiates a Phase 2b Trial of Dalcinonacog Alfa for the Treatment of Hemophilia B,GlobeNewswire
